757
Views
0
CrossRef citations to date
0
Altmetric
Critical Care Nephrology and Continuous Kidney Replacement Therapy

Hepatic function markers as prognostic factors in patients with acute kidney injury undergoing continuous renal replacement therapy

, , , , , & show all
Article: 2352127 | Received 28 Nov 2023, Accepted 01 May 2024, Published online: 21 May 2024

References

  • Doi K, Nishida O, Shigematsu T, et al. The Japanese clinical practice guideline for acute kidney injury 2016. J Intensive Care. 2018;6(1):48. doi: 10.1186/s40560-018-0308-6.
  • Iwagami M, Yasunaga H, Noiri E, et al. Current state of continuous renal replacement therapy for acute kidney injury in Japanese intensive care units in 2011: analysis of a national administrative database. Nephrol Dial Transplant. 2015;30(6):988–995. doi: 10.1093/ndt/gfv069.
  • Egi M, Ogura H, Yatabe T, et al. The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020). J Intensive Care. 2021;9(1):53. doi: 10.1186/s40560-021-00555-7.
  • Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol. 2008;3(3):844–861. doi: 10.2215/CJN.05191107.
  • Vincent JL, Moreno R, Takala J, et al. The SOFA (sepsis-related organ failure assessment) score to ­describe organ dysfunction/failure. On behalf of the working group on sepsis-Related problems of the european society of intensive care medicine. Intensive Care Med. 1996;22(7):707–710. doi: 10.1007/BF01709751.
  • Wang H, Kang X, Shi Y, et al. SOFA score is superior to APACHE-II score in predicting the prognosis of critically ill patients with acute kidney injury undergoing continuous renal replacement therapy. Ren Fail. 2020;42(1):638–645. doi: 10.1080/0886022X.2020.1788581.
  • Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810. doi: 10.1001/jama.2016.0287.
  • Schupp T, Weidner K, Rusnak J, et al. Diagnostic and prognostic value of the AST/ALT ratio in patients with sepsis and septic shock. Scand J Gastroenterol. 2023;58(4):392–402. doi: 10.1080/00365521.2022.2131331.
  • Kramer L, Jordan B, Druml W, et al. Incidence and prognosis of early hepatic dysfunction in critically ill patients–a prospective multicenter study. Crit Care Med. 2007;35(4):1099–1104. doi: 10.1097/01.CCM.0000259462.97164.A0.
  • Farag M, Veres G, Szabó G, et al. Hyperbilirubinaemia after cardiac surgery: the point of no return. ESC Heart Fail. 2019;6(4):694–700. doi: 10.1002/ehf2.12447.
  • Sawangkajohn W, Luvria V, Leeratanakachorn N, et al. Re-rising of total bilirubin level after postoperative day 3 (The V pattern) predicting liver failure and survival of patients who underwent hepatectomy for cholangiocarcinoma. Asian Pac J Cancer Prev. 2020;21(12):3573–3578. doi: 10.31557/APJCP.2020.21.12.3573.
  • Zanetto A, Rinder HM, Campello E, et al. Acute kidney injury in decompensated cirrhosis is associated with both hypo-coagulable and hyper-coagulable features. Hepatology. 2020;72(4):1327–1340. doi: 10.1002/hep.31443.
  • Zanetto A, Northup P, Roberts L, et al. Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation. J Hepatol. 2023;78(5):1037–1047. doi: 10.1016/j.jhep.2023.01.010.
  • Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005;294(7):813–818. doi: 10.1001/jama.294.7.813.
  • Khwannimit B, Bhurayanontachai R, Vattanavanit V. Comparison of the accuracy of three early warning scores with SOFA score for predicting mortality in adult sepsis and septic shock patients admitted to intensive care unit. Heart Lung. 2019;48(3):240–244. doi: 10.1016/j.hrtlng.2019.02.005.
  • Botros M, Sikaris KA. The De Ritis ratio: the test of time. Clin Biochem Rev. 2013;34:117–130.
  • Woźnica EA, Inglot M, Woźnica RK, et al. Liver dysfunction in sepsis. Adv Clin Exp Med. 2018;27(4):547–551. doi: 10.17219/acem/68363.
  • Patel JJ, Taneja A, Niccum D, et al. The association of serum bilirubin levels on the outcomes of severe sepsis. J Intensive Care Med. 2015;30(1):23–29. doi: 10.1177/0885066613488739.
  • Zhai R, Sheu CC, Su L, et al. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Thorax. 2009;64(9):784–790. doi: 10.1136/thx.2009.113464.
  • Pierrakos C, Velissaris D, Felleiter P, et al. Increased mortality in critically ill patients with mild or moderate hyperbilirubinemia. J Crit Care. 2017;40:31–35. doi: 10.1016/j.jcrc.2017.01.017.
  • Samsky MD, Patel CB, DeWald TA, et al. Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol. 2013;61(24):2397–2405. doi: 10.1016/j.jacc.2013.03.042.
  • Adamson C, Cowan LM, de Boer RA, et al. Liver tests and outcomes in heart failure with reduced ejection fraction: findings from DAPA-HF. Eur J Heart Fail. 2022;24(10):1856–1868. doi: 10.1002/ejhf.2649.
  • Jhee JH, Park JY, An JN, et al. Cumulative fluid balance and mortality in elderly patients with acute kidney injury requiring continuous renal-replacement therapy: a multicenter prospective cohort study. Kidney Res Clin Pract. 2020;39(4):414–425. doi: 10.23876/j.krcp.20.089.
  • Chen X, Bai M, Zhao L, et al. Time to peak bilirubin concentration and advanced AKI were associated with increased mortality in rheumatic heart valve replacement surgery patients with severe postoperative hyperbilirubinemia: a retrospective cohort study. BMC Cardiovasc Disord. 2021;21(1):16. doi: 10.1186/s12872-020-01830-5.
  • Zhao PY, Yao RQ, Ren C, et al. De Ritis ratio as a significant prognostic factor in patients with sepsis: a retrospective analysis. J Surg Res. 2021;264:375–385. doi: 10.1016/j.jss.2021.03.018.
  • Liu H, Ding C, Hu L, et al. The association between AST/ALT ratio and all-cause and cardiovascular mortality in patients with hypertension. Medicine (Baltimore). 2021;100(31):e26693. doi: 10.1097/MD.0000000000026693.
  • Yokoyama M, Watanabe T, Otaki Y, et al. Association of the aspartate aminotransferase to alanine aminotransferase ratio with BNP level and cardiovascular mortality in the general population: the Yamagata study 10-year follow-up. Dis Markers. 2016;2016:4857917–4857919. doi: 10.1155/2016/4857917.
  • Raurich JM, Llompart-Pou JA, Ferreruela M, et al. Hypoxic hepatitis in critically ill patients: incidence, etiology and risk factors for mortality. J Anesth. 2011;25(1):50–56. doi: 10.1007/s00540-010-1058-3.
  • Fuhrmann V, Kneidinger N, Herkner H, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med. 2009;35(8):1397–1405. doi: 10.1007/s00134-009-1508-2.
  • Henrion J, Descamps O, Luwaert R, et al. Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol. 1994;21(5):696–703. doi: 10.1016/s0168-8278(94)80226-2.
  • He M, Huang J, Li X, et al. Risk factors for mortality in sepsis patients without lactate levels increasing early. Emerg Med Int. 2023;2023:6620157. doi: 10.1155/2023/6620157.
  • Kim SG, Lee J, Yun D, et al. Hyperlactatemia is a predictor of mortality in patients undergoing continuous renal ­replacement therapy for acute kidney injury. BMC Nephrol. 2023;24(1):11. doi: 10.1186/s12882-023-03063-y.